These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 9864392)
1. Host cell-dependent replication of HIV-1 gag MA, CA, and NC mutants are independent of the functions of Vif and Vpu. Shimano R; Inubushi R; Adachi A Int J Mol Med; 1999 Jan; 3(1):91-4. PubMed ID: 9864392 [TBL] [Abstract][Full Text] [Related]
2. Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells. Koh K; Miyaura M; Yoshida A; Sakurai A; Fujita M; Adachi A Microbes Infect; 2000 Oct; 2(12):1419-23. PubMed ID: 11099927 [TBL] [Abstract][Full Text] [Related]
3. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants. D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721 [TBL] [Abstract][Full Text] [Related]
4. Viral factors involved in adapter-related protein complex 2 alpha 1 subunit-mediated regulation of human immunodeficiency virus type 1 replication. Sapsutthipas S; Kitagawa Y; Tokunaga K; Ikuta K; Kameoka M Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):311-9. PubMed ID: 21710851 [TBL] [Abstract][Full Text] [Related]
5. Exchangeability of accessory Vif and Vpu proteins between various HIV/SIVs (review). Adachi A; Iida S; Fukumori T; Tamaki M; Inubushi R; Shimano R; Oshima Y; Akari H; Koyama AH Int J Mol Med; 1999 Feb; 3(2):193-7. PubMed ID: 9917529 [TBL] [Abstract][Full Text] [Related]
6. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions. Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382 [TBL] [Abstract][Full Text] [Related]
7. The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release. Lee YH; Schwartz MD; Panganiban AT Virology; 1997 Oct; 237(1):46-55. PubMed ID: 9344906 [TBL] [Abstract][Full Text] [Related]
8. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Arrigo SJ; Chen IS Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422 [TBL] [Abstract][Full Text] [Related]
9. Re-analysis of human immunodeficiency virus type 1 isolates from Cyprus and Greece, initially designated 'subtype I', reveals a unique complex A/G/H/K/? mosaic pattern. Paraskevis D; Magiorkinis M; Vandamme AM; Kostrikis LG; Hatzakis A J Gen Virol; 2001 Mar; 82(Pt 3):575-580. PubMed ID: 11172098 [TBL] [Abstract][Full Text] [Related]
10. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. Aldrovandi GM; Zack JA J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668 [TBL] [Abstract][Full Text] [Related]
11. [Functional roles of HIV-1 accessory genes for its pathogenicity]. Adachi A; Kamada K; Hatcho K; Yamashita T; Uchiyama T; Nomaguchi M Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1261-7. PubMed ID: 17824250 [No Abstract] [Full Text] [Related]
12. HIV accessory proteins: emerging therapeutic targets. Miller RH; Sarver N Mol Med; 1995 Jul; 1(5):479-85. PubMed ID: 8529114 [No Abstract] [Full Text] [Related]
13. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
14. Cell-dependent function of HIV-1 Vif for virus replication (Review). Inubushi R; Adachi A Int J Mol Med; 1999 May; 3(5):473-6. PubMed ID: 10202177 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a novel DNA vaccine cassette expressing multiple human immunodeficiency virus (HIV-1) accessory genes. Ayyavoo V; Kudchodkar S; Ramanathan MP; Le P; Muthumani K; Megalai NM; Dentchev T; Santiago-Barrios L; Mrinalini C; Weiner DB AIDS; 2000 Jan; 14(1):1-9. PubMed ID: 10714562 [TBL] [Abstract][Full Text] [Related]
16. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. Cimarelli A; Luban J J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286 [TBL] [Abstract][Full Text] [Related]
17. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841 [TBL] [Abstract][Full Text] [Related]
18. Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. Bouyac M; Rey F; Nascimbeni M; Courcoul M; Sire J; Blanc D; Clavel F; Vigne R; Spire B J Virol; 1997 Mar; 71(3):2473-7. PubMed ID: 9032385 [TBL] [Abstract][Full Text] [Related]
19. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag. Sova P; Volsky DJ; Wang L; Chao W J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958 [TBL] [Abstract][Full Text] [Related]
20. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]